Moomoo AI 已提取核心信息
Bruush Oral Care Inc. completed two significant financing transactions in January 2024. The company closed a private placement on January 1, 2024, with Generating Alpha Ltd., raising $500,000 through the issuance of a pre-funded common share purchase warrant exercisable for 16,500,000 common shares at $0.001 each. Additionally, Bruush Oral Care agreed to file a registration statement for these shares within 45 days post-closing. On the same day, the company also entered into a convertible note financing agreement with Generating Alpha Ltd. for up to $6 million, with an initial funding of $1.5 million received on January 5, 2024. The note, maturing in one year with an interest rate of 12% or WSJ Prime Rate plus 3.5%, is convertible into common shares at a price of $0.1625 per share or 80% of the lowest...Show More
Bruush Oral Care Inc. completed two significant financing transactions in January 2024. The company closed a private placement on January 1, 2024, with Generating Alpha Ltd., raising $500,000 through the issuance of a pre-funded common share purchase warrant exercisable for 16,500,000 common shares at $0.001 each. Additionally, Bruush Oral Care agreed to file a registration statement for these shares within 45 days post-closing. On the same day, the company also entered into a convertible note financing agreement with Generating Alpha Ltd. for up to $6 million, with an initial funding of $1.5 million received on January 5, 2024. The note, maturing in one year with an interest rate of 12% or WSJ Prime Rate plus 3.5%, is convertible into common shares at a price of $0.1625 per share or 80% of the lowest volume-weighted average price of the ten trading days prior to conversion. The note includes full ratchet anti-dilution protections and additional terms in the event of default. EF Hutton LLC served as the placement agent for the financing. The company is required to file an initial registration statement for the convertible note within 30 days following January 1, 2024.
Bruush Oral Care Inc. 于 2024 年 1 月完成了两笔重大融资交易。该公司于2024年1月1日完成了私募配售，Generating Alpha Ltd. 通过发行预先筹集资金的普通股购买权证筹集了50万美元，该认股权证可行使16,500,000股普通股，每股0.001美元。此外，Bruush Oral Care同意在收盘后45天内提交这些股票的注册声明。同一天，该公司还与Generating Alpha Ltd.签订了高达600万美元的可转换票据融资协议，初始资金为150万美元，于2024年1月5日收到。该票据将在一年内到期，利率为12％或华尔街日报最优惠利率加上3.5...展开全部
Bruush Oral Care Inc. 于 2024 年 1 月完成了两笔重大融资交易。该公司于2024年1月1日完成了私募配售，Generating Alpha Ltd. 通过发行预先筹集资金的普通股购买权证筹集了50万美元，该认股权证可行使16,500,000股普通股，每股0.001美元。此外，Bruush Oral Care同意在收盘后45天内提交这些股票的注册声明。同一天，该公司还与Generating Alpha Ltd.签订了高达600万美元的可转换票据融资协议，初始资金为150万美元，于2024年1月5日收到。该票据将在一年内到期，利率为12％或华尔街日报最优惠利率加上3.5％，可转换为普通股，价格为每股0.1625美元，或转换前十个交易日最低成交量加权平均价格的80％。该票据包括全面的棘轮反稀释保护和违约情况下的附加条款。EF Hutton LLC担任了本次融资的配售代理。该公司必须在2024年1月1日后的30天内提交可转换票据的初始注册声明。
有用
没用